Overview
Lobbying Costs
150,000€
Financial year: Jan 2024 - Dec 2024
Lobbyists (Full time equivalent)
1.25 Fte (3)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Veristat
EU Transparency Register
31442479070-19 First registered on 02 Jul 2012
Goals / Remit
Veristat LLC is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies. Our scientific experts design and conduct the global activities required for any clinical, regulatory, or commercialization program comprehensively and efficiently.
Veristat meets clients’ needs through every stage of the product lifecycle. Our team has a proven track record in specific areas of expertise & excellent understanding of products’ lifecycle.
Public Affairs Services: Veristat advises organizations on engaging in the EU debate to shape regulatory & policy frameworks. Our team has extensive hands-on experience & proven success in supporting clients to contribute to EU healthcare laws & policies. Our services comprise strategic & operational public affairs support, intelligence, advocacy support & association management.Main EU files targeted
- EU Pharmaceutical Strategy
- European Health Union, HERA
- Implementation of Medical Devices Regulation and In-vitro Diagnostics Regulation
- Orphan Medicinal Products Regulation, Pediatric Regulation and their revision
- Revision of the EU general pharmaceutical legislation
- Incentives on medicinal products
- Advanced Therapy Medicinal Products Regulation
- Planned EU Biotech Act
- Planned EU Critical Medicines Act
- Europe’s Beating Cancer Plan
- Clinical Trials Regulation and Clinical Trials Information System
- European Medicines Agency policy on publication of
clinical data for medicinal products for human use
- Implementation of Regulation on Health Technology Assessment
- Cross-border healthcare
- EUnetHTA
- EU pharmacovigilance system
- EU personalized medicine activities such as use of '-omics' technologies in the development of personalized medicine
- Access to Medicines
- Shortages of medicinal products and medical devices
- Horizon Europe
- European Data Strategy, Artificial Intelligence and Cybersecurity
- Data Governance Act and Data Act
- Digital infrastructure and cybersecurity
- Regulation on Artificial Intelligence
- European Health Data Space
- General Data Protection Regulation
- European Green Deal
- Circular Economy Action Plan
- EU strategy for chemicals sustainability
- Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
- PFAS regulations
- Planned Chemicals Industry Package
- EU industrial strategy
- Planned EU Clean Industrial Deal
- EU Competitiveness Compass
- Planned Single Market Strategy
- Planned EU Innovation Act
- Planned EU Research Area ActAddress
Head Office
134 Turnpike RoadSuite 200
Southborough MA 01772
UNITED STATESEU Office
Aeschenvorstadt 52
Basel 4051
SWITZERLANDWebsite
-
People
Total lobbyists declared
3
Employment time Lobbyists 50% 2 25% 1 Lobbyists (Full time equivalent)
1.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
SFL is a member of Medtech & Pharma Platform (MPP).
SFL is a member of SWISS MEDTECH.
SFL is a member of the Round Table on Antibiotics.
SFL is a member of the British-Swiss Chamber of Commerce.Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Jan 2024 - Dec 2024
Lobbying costs for closed financial year
150,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount Medtech & Pharma Platform (MPP) Our work as leading the Secretariat covers widely all policies and legislation relevant to the combined products, i.e. products consisting of a combined use of a medicinal product, medical device or in vitro diagnostic, including those with a digital component. 100,000€ - 199,999€ F. Hoffmann-La Roche Ltd Our work covers widely health policies and legislation in the European Union. In addition, policies and legislations impacting conditions applicable to the establishment and running of corporations are also covered. 50,000€ - 99,999€ Clients for current financial year
Clients list
Name F. Hoffmann-La Roche Ltd Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Veristat supports its clients with impact analysis and strategic communication advice on the dossiers and activities listed under ‘Main EU initiatives, policies and legislative files monitored by your organisation’. Veristat advises on internal organizational matters to help clients formulate aligned positions and speak with one voice to regulators, policymakers and other stakeholders.
Other activities
None declared
Meetings
Meetings
None declared